Not medical advice
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Symptune does not diagnose, treat, or provide clinical guidance. Always consult a qualified healthcare provider before making any changes to your protocol or treatment.
Subcutaneous or intramuscular. Ask this question on any TRT forum and you'll get a hundred confident, contradictory answers within an hour. It's one of the most argued-about decisions in TRT, which is odd, because for most people it's one of the least consequential.
Both routes work. Both deliver testosterone into your system reliably. The differences are real but smaller than the volume of debate suggests, and the right choice is usually whichever one you'll actually do consistently.
What the two routes are
Intramuscular (IM) injection deposits testosterone into muscle tissue, typically the glute, thigh, or delt, using a longer needle. This is the traditional route, the one most clinics default to, and the one most older protocols assume.
Subcutaneous (SubQ) injection deposits it into the fat layer just under the skin, using a shorter, thinner needle, often into the abdomen or thigh. It's become more common in recent years, partly because the injections are easier and less intimidating to self-administer.
What actually differs
The practical differences come down to a few things, most of which favor SubQ for the person doing the injecting:
- Comfort and ease - SubQ uses a smaller needle and is generally easier to self-administer, especially for men who find sticking a long needle into their glute unpleasant. For a treatment you'll do for years, "the one you don't dread" is not a trivial advantage
- Absorption profile - SubQ tends to absorb a little more slowly and steadily from the fat depot, which some men find gives smoother levels. The effect exists but is modest, and individual variation is large
- Site reactions - some men get small lumps, redness, or irritation at SubQ sites. Others get none. IM has its own discomfort tradeoffs. Neither is universally better tolerated
- Blood level differences - studies comparing the two routes generally find both achieve adequate testosterone levels. Reported differences in peak and trough tend to be small enough that they're swamped by other variables like dose and frequency
Notice what's not on that list: a dramatic difference in how you feel. For most men, switching routes at the same dose and frequency produces a change that's hard to distinguish from noise.
The variable that gets miscredited
Here's the trap. A lot of men switch from IM to SubQ and simultaneously change their frequency, going from a larger weekly IM shot to smaller, more frequent SubQ injections. Then they feel better and credit the route.
But they changed two things at once, and the one more likely to matter is the frequency, not the route. More frequent, smaller doses tend to smooth out the peaks and troughs that cause symptom swings. That's a real effect with a clear mechanism. Attributing it to SubQ instead of to frequency is a classic confounded change. If you want to know what the route actually does for you, you have to change only the route and hold frequency and dose constant.
How to actually evaluate a switch
The reason route switches feel more consequential than they are is that they come loaded with expectation. You read that SubQ gives smoother levels, you switch, and you're primed to notice smoothness. That's exactly the situation where a few good days get over-read as proof.
Evaluate it the way you'd evaluate any protocol change. Establish where you are on your current route across a few weeks. Switch the single variable. Track the same daily state measures across the following weeks. Then compare the ranges, not the memory. If SubQ genuinely smooths your levels, it should show up as reduced day-to-day variation in your energy and mood scores, not just a vague sense that things are better.
The honest bottom line
For most men, the injection route is a comfort and convenience decision, not a make-or-break protocol variable. Pick the one you'll do consistently and without dread, because adherence over years matters far more than a small absorption difference. If you have a specific problem, like consistent site reactions on one route, that's a real reason to switch. Chasing a feeling that switching route will unlock something the dose and frequency haven't is usually chasing the wrong variable.
If you do switch, do it cleanly, one variable at a time, and let your own tracked data tell you whether it changed anything. That's a more reliable answer than any forum thread will give you, because it's an answer about your body specifically rather than someone else's.